Pacira BioSciences (PCRX) Non-Current Deferred Tax Liability (2025 - 2026)

Pacira BioSciences' Non-Current Deferred Tax Liability history runs 2 years deep, the most recent figure standing at $4.1 million for Q1 2026.

• On a quarterly basis, Non-Current Deferred Tax Liability fell 41.5% year-over-year to $4.1 million in Q1 2026; TTM through Mar 2026 was $4.1 million, a 41.5% decrease from a year earlier, with the FY2025 full-year figure at $4.2 million, changed N/A from the prior year.
• Non-Current Deferred Tax Liability declined to $4.1 million in Q1 2026 per PCRX's latest filing, from $4.2 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $7.0 million in Q1 2025 and bottomed at $4.1 million in Q1 2026.